Optimization of the synthesis of BET BD2 selective inhibitor XY153

Chem Biodivers. 2024 Feb;21(2):e202301584. doi: 10.1002/cbdv.202301584. Epub 2024 Jan 12.

Abstract

XY153 is a promising BET BD2 inhibitor with an IC50 value of 0.79 nM against BRD4 BD2. It shows 354-fold selectivity over BRD4-BD1 and 6-fold selectivity over other BET BD2 domains. However, the reported synthesis route of XY153 and its derivatives are extremely poor-yielding. After the synthesis of three key fragments, XY153 can only be obtained with a yield of 1.3 % in the original four-step reaction. In this study, we reported a three-step alternative route in the synthesis process of XY153. The reaction conditions for this route were thoroughly investigated and optimized, resulting in a significantly improved yield of 61.5 %. This efficient synthesis route establishes a robust chemical foundation for the rapid synthesis of XY153 derivatives as BET BD2 inhibitors in the near future.

Keywords: BET BD2; Bromodomain; Synthesis Optimization; Synthetic Route Design; XY153.

MeSH terms

  • Antineoplastic Agents*
  • Cell Cycle Proteins
  • Nuclear Proteins / chemistry
  • Transcription Factors* / chemistry

Substances

  • Transcription Factors
  • Nuclear Proteins
  • Antineoplastic Agents
  • Cell Cycle Proteins